These mutations are mostly seen in germinal center (GC) derived diffuse large B-cell lymphoma and FL because EZH2 plays a major role in GC development and is greatly expressed within pro-B cells, which directly controls IGF1R expression to activate the PI3K pathway, therefore making it an interesting gene to evaluate in this study. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.